Clinical trial NCT02895113 - References

Diabetes — Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes

Citation(s)

•   Davì G, Patrono C
  Platelet activation and atherothrombosis. N Engl J Med. 2007 Dec 13;357(24):2482-94. Review.
•   Larivière R, Moreau C, Rodrigue ME, Lebel M
  Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats. Prostaglandins Leukot Essent Fatty Acids. 2004 Aug;71(2):103-9.
•   Lomnicka M, Karouni K, Sue M, Wessel LA, Bing RJ
  Effects of nonsteroidal anti-inflammatory drugs on prostacyclin and thromboxane in the kidney. Pharmacology. 2003 Jul;68(3):147-53.
•   Pastori D, Pignatelli P, Perticone F, Sciacqua A, Carnevale R, Farcomeni A, Basili S, Corazza GR, Davì G, Lip GY, Violi F; ARAPACIS (Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study) study group
  Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. Int J Cardiol. 2016 Aug 14;223:619-624. doi: 10.1016/j.ijcard.2016.08.224. [Epub ahead of print]
•   Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, De Salvo A, Satta MA, Peskar BA
  Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res. 1980 Feb 1-15;17(3-4):317-27.
•   Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members
  Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
•   Wild S, Roglic G, Green A, Sicree R, King H
  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047-53.

Effect of Aspirin on Renal Disease Progression in Patients With Type 2 Diabetes: a Multicentre Double-blind, Placebo-controlled, Randomised Trial. The LEDA (renaL disEase Progression by Aspirin in Diabetic pAtients) Study.

Details for clinical trial NCT02895113